Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
E22 guideline should incorporate caregiver feedback, according to responses submitted by industry groups and manufacturers to ...
Many of the bispecific antibodies (BsAbs) approved by global regulators have yet to demonstrate robust clinical benefit ...
The US Food and Drug Administration (FDA) has submitted its budget proposal to Congress, outlining its spending priorities for fiscal year 2027. The budget request totals $7.2 billion, including $3.3 ...
US Food and Drug Administration (FDA) officials credited recent advancements in regulatory science and flexibilities with ...
The US Food and Drug Administration (FDA) has issued a warning letter to a medical spa company in Texas for violating the ...
A European Medicines Agency (EMA) group has recommended actions the regulator and industry can take to accelerate regulatory ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results